Home/Filings/4/0001919170-25-000004
4//SEC Filing

Glessner Coleen 4

Accession 0001919170-25-000004

CIK 0001367644other

Filed

Oct 15, 8:00 PM ET

Accepted

Oct 16, 4:21 PM ET

Size

5.1 KB

Accession

0001919170-25-000004

Insider Transaction Report

Form 4
Period: 2025-10-07
Glessner Coleen
EVP, Quality & Ethics, and CPL
Transactions
  • Sale

    Common Stock

    2025-10-07$10.00/sh30,608$306,080144,319 total
Footnotes (2)
  • [F1]All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on December 2, 2024 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act").
  • [F2]All shares sold at an exact price of $10.00.

Issuer

Emergent BioSolutions Inc.

CIK 0001367644

Entity typeother

Related Parties

1
  • filerCIK 0001919170

Filing Metadata

Form type
4
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 4:21 PM ET
Size
5.1 KB